Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Jun 14;45(6):521-524.
doi: 10.3760/cma.j.cn121090-20240523-00186.

[To construct Chinese hematology community]

[Article in Chinese]
X J Huang  1 , Z L Xu  1
Affiliations

[To construct Chinese hematology community]

[Article in Chinese]
X J Huang et al. Zhonghua Xue Ye Xue Za Zhi. .

Abstract
in English, Chinese

The development of hematology in China has gradually begun since the 1950s. After several generations of hard work, it has grown into a young but vibrant discipline. The development of Chinese hematology has experienced rapid rise and steady growth, but there is still a gap with the international level of hematology development. Only by constructing a Chinese community of hematology and forming a joint force to promote the development of hematology can we better realize the Chinese Dream in the field of hematology.

中国血液学的发展自20世纪50年代逐渐拉开序幕，历经几代人的艰苦奋斗、薪火相传，已成长为一个年轻但充满活力的学科。中国血液学的发展经历了快速崛起和稳步成长，但与国际血液学发展水平仍有差距。只有通过构建中国血液学共同体，形成推动血液学发展的合力，才能更好地实现血液学领域的中国梦。.

Keywords: China; Community; Hematology.

PubMed Disclaimer

References

    1. Wang ZY, Chen Z. Acute promyelocytic leukemia: from highly fatal to highly curable[J] Blood. 2008;111(5):2505–2515. doi: 10.1182/blood-2007-07-102798. - DOI - PubMed
    1. Steering committee of the blood and marrow transplant clinical trials network. The blood and marrow transplant clinical trials network: an effective infrastructure for addressing important issues in hematopoietic cell transplantation[J] Biol Blood Marrow Transplant. 2016;22(10):1747–1757. doi: 10.1016/j.bbmt.2016.07.003. - DOI - PMC - PubMed
    1. Chang YJ, Pei XY, Huang XJ. Haematopoietic stem-cell transplantation in China in the era of targeted therapies: current advances, challenges, and future directions[J] Lancet Haematol. 2022;9(12):e919–e929. doi: 10.1016/S2352-3026(22)00293-9. - DOI - PubMed
    1. Handgretinger R. Haploidentical transplantation: the search for the best donor[J] Blood. 2014;124(6):827–828. doi: 10.1182/blood-2014-06-582460. - DOI - PMC - PubMed
    1. Hu Y, Feng J, Gu T, et al. CAR T-cell therapies in China: rapid evolution and a bright future[J] Lancet Haematol. 2022;9(12):e930–e941. doi: 10.1016/S2352-3026(22)00291-5. - DOI - PubMed